SFB-F44 - cell signaling in chronic CNS disorders
Other relevant publication of Gregor Wenning
2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005
2011
Höglinger GU, Melhem NM, Dickson DW, et.al.
Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy.
Nat Genet. 2011 Jun 19;43(7):699-705. doi: 10.1038/ng.859. PMID: 21685912 [PubMed - in process]
Wenning GK, Litvan I, Tolosa E.
Milestones in atypical and secondary Parkinsonisms.
Mov Disord. 2011 May;26(6):1083-95. doi: 10.1002/mds.23713.
Stemberger S, Jamnig A, Stefanova N, Lepperdinger G, Reindl M, Wenning GK.
Mesenchymal stem cells in a transgenic mouse model of multiple system atrophy: immunomodulation and neuroprotection.
PLoS One. 2011;6(5):e19808. Epub 2011 May 18.
Stemberger S, Scholz SW, Singleton AB, Wenning GK.
Genetic players in multiple system atrophy: unfolding the nature of the beast.
Neurobiol Aging. 2011 May 20.
Wenning GK, Krismer F, Poewe W.
New insights into atypical parkinsonism.
Curr Opin Neurol. 2011 Aug;24(4):331-8.
Fellner L, Jellinger KA, Wenning GK, Stefanova N.
Glial dysfunction in the pathogenesis of α-synucleinopathies: emerging concepts.
Acta Neuropathol. 2011 Jun;121(6):675-93. Epub 2011 May 12.
Traon AP, Amarenco G, Duerr S, Kaufmann H, Lahrmann H, Shaftman SR, Tison F, Wenning GK, Goetz CG, Poewe W, Sampaio C, Schrag A, Stebbins GT, Rascol O.
The Movement disorders task force review of dysautonomia rating scales in Parkinson's disease with regard to symptoms of orthostatic hypotension.
Mov Disord. 2011 May 5. doi: 10.1002/mds.23742.
Moreno-López C, Santamaría J, Salamero M, Del Sorbo F, Albanese A, Pellecchia MT, Barone P, Overeem S, Bloem B, Aarden W, Canesi M, Antonini A, Duerr S, Wenning GK, Poewe W, Rubino A, Meco G, Schneider SA, Bhatia KP, Djaldetti R, Coelho M, Sampaio C, Cochen V, Hellriegel H, Deuschl G, Colosimo C, Marsili L, Gasser T, Tolosa E.
Excessive daytime sleepiness in multiple system atrophy (SLEEMSA study).
Arch Neurol. 2011 Feb;68(2):223-30.
Stemberger S, Wenning GK.
Modelling progressive autonomic failure in MSA: where are we now?
J Neural Transm. 2011 May;118(5):841-7.
Köllensperger M, Krismer F, Pallua A, Stefanova N, Poewe W, Wenning GK. (2011)
Erythropoietin is neuroprotective in a transgenic mouse model of multiple system atrophy.
Mov Disord. 2011 Feb 15;26(3):507-15. doi: 10.1002/mds.23474. Epub 2011 Jan 6.
Goebel G, Seppi K, Donnemiller E, Warwitz B, Wenning GK, Virgolini I, Poewe W, Scherfler C.
A novel computer-assisted image analysis of [123I]β-CIT SPECT images improves the diagnostic accuracy of parkinsonian disorders.
Eur J Nucl Med Mol Imaging. 2011 Apr;38(4):702-10. Epub 2010 Dec 21.
Geser F, Malunda JA, Hurtig HI, Duda JE, Wenning GK, Gilman S, Low PA, Lee VM, Trojanowski JQ.
TDP-43 pathology occurs infrequently in multiple system atrophy.
Neuropathol Appl Neurobiol. 2011 Jun;37(4):358-365. doi: 10.1111/j.1365-2990.2010.01136.x.
2010
Köllensperger M, Geser F, Ndayisaba JP, Boesch S, Seppi K, Ostergaard K, Dupont E, Cardozo A, Tolosa E, Abele M, Klockgether T, Yekhlef F, Tison F, Daniels C, Deuschl G, Coelho M, Sampaio C, Bozi M, Quinn N, Schrag A, Mathias CJ, Fowler C, Nilsson CF, Widner H, Schimke N, Oertel W, Del Sorbo F, Albanese A, Pellecchia MT, Barone P, Djaldetti R, Colosimo C, Meco G, Gonzalez-Mandly A, Berciano J, Gurevich T, Giladi N, Galitzky M, Rascol O, Kamm C, Gasser T, Siebert U, Poewe W, Wenning GK; EMSA-SG.
Presentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registry.
Mov Disord. 2010 Nov 15;25(15):2604-12.
Wenning GK, Colosimo C.
Diagnostic criteria for multiple system atrophy and progressive supranuclear palsy.
Rev Neurol (Paris). 2010 Oct;166(10):829-33. Epub 2010 Sep 1. Review.
Stemberger S, Poewe W, Wenning GK, Stefanova N. (2010)
Targeted overexpression of human alpha-synuclein in oligodendroglia induces lesions linked to MSA -like progressive autonomic failure.
Exp Neurol. 2010 May 21.
Schunk E, Aigner C, Stefanova N, Wenning GK, Herzog H, Schwarzer C. (2010)
Kappa opioid receptor activation blocks progressive neurodegeneration after kainic acid injection.
Published Online: Jun 1 2010
2009
Peralta CM, Frauscher B, Seppi K, Wolf E, Wenning GK, Högl B, Poewe W. (2009)
Restless legs syndrome in Parkinson's disease.
Mov Disord. 2009 Oct 30;24(14):2076-80
Stefanova N, Bücke P, Duerr S, Wenning GK. (2009)
Multiple system atrophy: an update.
Lancet Neurol, 2009, 8(12):1172-8.
Osaki Y, Ben-Shlomo Y, Lees AJ, Wenning GK, Quinn NP.
A validation exercise on the new consensus criteria for multiple system atrophy.
Mov Disord. 2009 Oct 20. ]
Finke C, Siebert E, Plotkin M, Wenning GK, Reuter U.
Multiple system atrophy masking multiple sclerosis.
Clin Neurol Neurosurg. 2009 Sep 5.
Loscher WN, Wenning GK.
No need to droop your head in Parkinson's disease?
Parkinsonism Relat Disord. 2009 Nov;15(9):620.
Lipp A, Sandroni P, Ahlskog JE, Fealey RD, Kimpinski K, Iodice V, Gehrking TL, Weigand SD, Sletten DM, Gehrking JA, Nickander KK, Singer W, Maraganore DM, Gilman S, Wenning GK, Shults CW, Low PA.
Prospective differentiation of multiple system atrophy from Parkinson disease, with and without autonomic failure.
Arch Neurol. 2009 Jun;66(6):742-50.
Scholz SW, Houlden H, Schulte C, Sharma M, Li A, Berg D, Melchers A, Paudel R, Gibbs JR, Simon-Sanchez J, Paisan-Ruiz C, Bras J, Ding J, Chen H, Traynor BJ, Arepalli S, Zonozi RR, Revesz T, Holton J, Wood N, Lees A, Oertel W, Wüllner U, Goldwurm S, Pellecchia MT, Illig T, Riess O, Fernandez HH, Rodriguez RL, Okun MS, Poewe W, Wenning GK, Hardy JA, Singleton AB, Gasser T.
SNCA variants are associated with increased risk for multiple system atrophy.
Ann Neurol. 2009 May;65(5):610-4.
Wenning GK, Stefanova N.
Recent developments in multiple system atrophy.
J Neurol. 2009 Nov;256(11):1791-808. Epub 2009 May 27.
Stefanova N, Hainzer M, Stemberger S, Couillard-Després S, Aigner L, Poewe W, Wenning GK.
Striatal transplantation for multiple system atrophy--are grafts affected by alpha-synucleinopathy?
Exp Neurol. 2009 Sep;219(1):368-71. Epub 2009 May 19.
Lim SY, Wadia P, Wenning GK, Lang AE.
Clinically probable multiple system atrophy with predominant parkinsonism associated with myotonic dystrophy type 2.
Mov Disord. 2009 Jul 15;24(9):1407-9. No abstract available.
Delazer M, Sinz H, Zamarian L, Stockner H, Seppi K, Wenning GK, Benke T, Poewe W.
Decision making under risk and under ambiguity in Parkinson's disease.
Neuropsychologia. 2009 Jul;47(8-9):1901-8.
Wenning GK, Brown R.
Dementia in multiple system atrophy: does it exist?
Eur J Neurol. 2009 May;16(5):551-2. No abstract available.
Ubhi K, Lee PH, Adame A, Inglis C, Mante M, Rockenstein E, Stefanova N, Wenning GK, Masliah E.
Mitochondrial inhibitor 3-nitroproprionic acid enhances oxidative modification of alpha-synuclein in a transgenic mouse model of multiple system atrophy.
J Neurosci Res. 2009 Sep;87(12):2728-39.
Diem-Zangerl A, Seppi K, Wenning GK, Trinka E, Ransmayr G, Oberaigner W, Poewe W.
Mortality in Parkinson's disease: a 20-year follow-up study.
Mov Disord. 2009 Apr 30;24(6):819-25.
Petzold A, Thompson EJ, Keir G, Quinn N, Holmberg B, Dizdar N, Wenning GK, Rascol O, Tolosa E, Rosengren L.
Longitudinal one-year study of levels and stoichiometry of neurofilament heavy and light chain concentrations in CSF in patients with multiple system atrophy.
J Neurol Sci. 2009 Apr 15;279(1-2):76-9. Epub 2009 Feb 4.
Köllensperger M, Stefanova N, Pallua A, Puschban Z, Dechant G, Hainzer M, Reindl M, Poewe W, Nikkhah G, Wenning GK.
Striatal transplantation in a rodent model of multiple system atrophy: effects on L-Dopa response.
J Neurosci Res. 2009 May 15;87(7):1679-85.
Tiefenthaler W, Wenning GK, Gruber H, Benzer A.
Sonographic diagnosis of catheter malposition in a patient with postoperative plexus lesion after right internal jugular vein catheterization--case report.
Middle East J Anesthesiol. 2009 Oct;20(3):443-5.
Köllensperger M, Wenning GK.
Assessing disease progression with MRI in atypical parkinsonian disorders.
Mov Disord. 2009;24 Suppl 2:S699-702.
Osaki Y, Ben-Shlomo Y, Lees AJ, Wenning GK, Quinn NP. (2009)
A validation exercise on the new consensus criteria for multiple system atrophy.
Mov Disord. 2009 Nov 15;24(15):2272-6.
Finke C, Siebert E, Plotkin M, Wenning GK, Reuter U. (2009)
Multiple system atrophy masking multiple sclerosis.
Clin Neurol Neurosurg. 2010 Jan;112(1):59-61. Epub 2009 Sep 6.
2008
Aziz NA, van der Burg JM, Landwehrmeyer GB, Brundin P, Stijnen T; EHDI Study Group, Roos RA.
Weight loss in Huntington disease increases with higher CAG repeat number.
Neurology. 2008 Nov 4;71(19):1506-13.
Wenning GK, Stefanova N, Jellinger KA, Poewe W, Schlossmacher MG.
Multiple system atrophy: a primary oligodendrogliopathy.
Ann Neurol. 2008 Sep;64(3):239-46. Review.
Gilman S, Wenning GK, Low PA, Brooks DJ, Mathias CJ, Trojanowski JQ, Wood NW, Colosimo C, Dürr A, Fowler CJ, Kaufmann H, Klockgether T, Lees A, Poewe W, Quinn N, Revesz T, Robertson D, Sandroni P, Seppi K, Vidailhet M.
Second consensus statement on the diagnosis of multiple system atrophy.
Neurology. 2008 Aug 26;71(9):670-6.
Köllensperger M, Geser F, Seppi K, Stampfer-Kountchev M, Sawires M, Scherfler C, Boesch S, Mueller J, Koukouni V, Quinn N, Pellecchia MT, Barone P, Schimke N, Dodel R, Oertel W, Dupont E, Østergaard K, Daniels C, Deuschl G, Gurevich T, Giladi N, Coelho M, Sampaio C, Nilsson C, Widner H, Sorbo FD, Albanese A, Cardozo A, Tolosa E, Abele M, Klockgether T, Kamm C, Gasser T, Djaldetti R, Colosimo C, Meco G, Schrag A, Poewe W, Wenning GK; European MSA Study Group.
Red flags for multiple system atrophy.
Mov Disord. 2008 Jun 15;23(8):1093-9.
Quinn N, Barker RA, Wenning GK.Clin Pharmacol Ther.
Are trials of intravascular infusions of autologous mesenchymal stem cells in patients with multiple system atrophy currently justified, and are they effective?
2008 May;83(5):663-5.
Sinz H, Zamarian L, Benke T, Wenning GK, Delazer M.
Impact of ambiguity and risk on decision making in mild Alzheimer's disease.
Neuropsychologia. 2008;46(7):2043-55. Epub 2008 Feb 8.
Stefanova N, Poewe W, Wenning GK.
Rasagiline is neuroprotective in a transgenic model of multiple system atrophy.
Exp Neurol. 2008 Apr;210(2):421-7. Epub 2007 Dec 4.
Schrag A, Wenning GK, Quinn N, Ben-Shlomo Y.
Survival in multiple system atrophy.
Mov Disord. 2008 Jan 30;23(2):294-6.
2007
Ransmayr G, Katzenschlager R, Dal-Bianco P, Wenning G, Bancher C, Jellinger K, Schmidt R, Poewe W. (2007)
Dementia with Lewy Bodies and its differentiation from Alzheimer's disease.
Neuropsychiatr. 2007;21(2):63-74.
Jellinger KA, Wenning GK, Seppi K. (2007)
Predictors of survival in dementia with lewy bodies and Parkinson dementia.
Neurodegener Dis. 2007;4(6):428-30.
Peralta C, Stampfer-Kountchev M, Karner E, Kollensperger M, Geser F, Wolf E, Seppi K, Benke T, Poewe W, Wenning GK. (2007)
Orthostatic hypotension and attention in Parkinson's disease with and without dementia.
J Neural Transm. 2007;114(5):585-8.
Kollensperger M, Stampfer-Kountchev M, Seppi K, Geser F, Frick C, Del Sorbo F, Albanese A, Gurevich T, Giladi N, Djaldetti R, Schrag A, Low PA, Mathias CJ, Poewe W, Wenning GK. (2007)
Progression of dysautonomia in multiple system atrophy: a prospective study of self-perceived impairment.
Eur J Neurol. 2007 Jan;14(1):66-72.
Loscher WN, Stampfer-Kountchev M, Sawires M, Seppi K, Mueller J, Szubski C, Hirnsperger K, Brenneis C, Poewe W, Wenning GK. (2007)
Abnormal responses to repetitive transcranial magnetic stimulation in multiple system atrophy.
Mov Disord. 2007 Jan 15;22(2):174-8.
Brenneis C, Egger K, Scherfler C, Seppi K, Schocke M, Poewe W, Wenning GK. (2007)
Progression of brain atrophy in multiple system atrophy : A longitudinal VBM study.
J Neurol. 2007 Feb;254(2):191-6.
Kollensperger M, Stefanova N, Reindl M, Poewe W, Wenning GK.(2007)
Loss of dopaminergic responsiveness in a double lesion rat model of the Parkinson variant of multiple system atrophy.
Mov Disord. 2007 Feb;22(3):353-8.
Stockner H, Sojer M, K KS, Mueller J, Wenning GK, Schmidauer C, Poewe W. (2007)
Midbrain sonography in patients with essential tremor.
Mov Disord. 2007 Feb;22(3):414-7.
Boesch SM, Wolf C, Seppi K, Felber S, Wenning GK, Schocke M. (2007)
Differentiation of SCA2 from MSA-C using proton magnetic resonance spectroscopic imaging.
J Magn Reson Imaging. 2007 Mar;25(3):564-9.
Boesch SM, Mueller J, Wenning GK, Poewe W. (2007)
Cervical dystonia in spinocerebellar ataxia type 2: Clinical and polymyographic findings.
J Neurol Neurosurg Psychiatry. 2007 May;78(5):520-2.
Stefanova N, Kollensperger M, Hainzer M, Cenci A, Poewe W, Wenning GK. (2007)
High dose levodopa therapy is not toxic in multiple system atrophy: Experimental evidence.
Mov Disord. 2007 May 15;22(7):969-73.
Holmberg B, Johansson JO, Poewe W, Wenning G, Quinn NP, Mathias C, Tolosa E, Cardozo A, Dizdar N, Rascol O, Slaoui T; Growth-Hormone MSA Study GroupMembers of the Growth-Hormone MSA Study Group and the European MSA Study Group are listed as an Appendix; European MSA Study Group (EMSA-SG). (2007)
Safety and tolerability of growth hormone therapy in multiple system atrophy: A double-blind, placebo-controlled study.
Mov Disord. 2007 Apr 27;22(8):1138-1144.
Hering S, Wenning GK, Seppi K, Poewe W, Mueller J. (2007)
An open trial of levetiracetam for segmental and generalized dystonia.
Mov Disord. 2007 Aug 15;22(11):1649-51.
Egger K, Mueller J, Schocke M, Brenneis C, Rinnerthaler M, Seppi K, Trieb T, Wenning GK, Hallett M, Poewe W. (2007)
Voxel based morphometry reveals specific gray matter changes in primary dystonia.
Mov Disord. 2007 Aug 15;22(11):1538-42.
Kollensperger M, Seppi K, Liener C, Boesch S, Heute D, Mair KJ, Mueller J, Sawires M, Scherfler C, Schocke MF, Donnemilier E, Virgolini I, Wenning GK, Poewe W. (2007)
Diffusion weighted imaging best discriminates PD from MSA-P: A comparison with tilt table testing and heart MIBG scintigraphy.
Mov Disord. 2007 Sep 15;22(12):1771-1776.
Martinez-Rodriguez JE, Seppi K, Cardozo A, Iranzo A, Stampfer-Kountchev M, Wenning G, Tolosa E, Hogl B, Santamaria J, Poewe W; SINBAR (Sleep Innsbruck Barcelona) group. (2007)
Cerebrospinal fluid hypocretin-1 levels in multiple system atrophy.
Mov Disord. 2007 Sep 15;22(12):1822-4.
Stefanova N, Reindl M, Neumann M, Kahle PJ, Poewe W, Wenning GK. (2007)
Microglial activation mediates neurodegeneration related to oligodendroglial alpha-synucleinopathy: Implications for multiple system atrophy.
Mov Disord. 2007 Nov 15;22(15):2196-203.
2006
Brenneis C, Boesch SM, Egger KE, Seppi K, Scherfler C, Schocke M, Wenning GK, Poewe W. (2006)
Cortical atrophy in the cerebellar variant of multiple system atrophy: a voxel-based morphometry study.
Mov Disord. 2006 Feb;21(2):159-65.
Geser F, Wenning GK, Seppi K, Stampfer-Kountchev M, Scherfler C, Sawires M, Frick C, Ndayisaba JP, Ulmer H, Pellecchia MT, Barone P, Kim HT, Hooker J, Quinn NP, Cardozo A, Tolosa E, Abele M, Klockgether T, Ostergaard K, Dupont E, Schimke N, Eggert KM, Oertel W, Djaldetti R, Poewe W; the European MSA Study Group. (2006)
Progression of multiple system atrophy (MSA): a prospective natural history study by the European MSA Study Group (EMSA SG).
Mov Disord. 2006 Feb;21(2):179-86.
Scherfler C, Schocke MF, Seppi K, Esterhammer R, Brenneis C, Jaschke W, Wenning GK, Poewe W. (2006)
Voxel-wise analysis of diffusion weighted imaging reveals disruption of the olfactory tract in Parkinson's disease.
Brain. 2006 Feb;129(Pt 2):538-42.
Metzger S, Bauer P, Tomiuk J, Laccone F, Didonato S, Gellera C, Soliveri P, Lange HW, Weirich-Schwaiger H, Wenning GK, Melegh B, Havasi V, Baliko L, Wieczorek S, Arning L, Zaremba J, Sulek A, Hoffman-Zacharska D, Basak AN, Ersoy N, Zidovska J, Kebrdlova V, Pandolfo M, Ribai P, Kadasi L, Kvasnicova M, Weber BH, Kreuz F, Dose M, Stuhrmann M, Riess O. (2006)
The S18Y polymorphism in the UCHL1 gene is a genetic modifier in Huntington's disease. Neurogenetics. 2006 Mar;7(1):27-30.
Ozawa T, Healy DG, Abou-Sleiman PM, Ahmadi KR, Quinn N, Lees AJ, Shaw K, Wullner U, Berciano J, Moller JC, Kamm C, Burk K, Josephs KA, Barone P, Tolosa E, Goldstein DB, Wenning G, Geser F, Holton JL, Gasser T, Revesz T, Wood NW; European MSA Study Group. (2006)
The alpha-synuclein gene in multiple system atrophy.
J Neurol Neurosurg Psychiatry. 2006 Apr;77(4):464-7.
Seppi K, Schocke MF, Mair KJ, Esterhammer R, Scherfler C, Geser F, Kremser C, Boesch S, Jaschke W, Poewe W, Wenning GK. (2006)
Progression of putaminal degeneration in multiple system atrophy: a serial diffusion MR study.
Neuroimage. 2006 May 15;31(1):240-5.
Schrag A, Geser F, Stampfer-Kountchev M, Seppi K, Sawires M, Köllensperger M, Scherfler C, Quinn N, Pellecchia MT, Barone P, del Sorbo F, Albanese A, Ostergaard K, Dupont E, Cardozo A, Tolosa E, Nilsson CF, Widner H, Lindvall O, Giladi N, Gurevich T, Daniels C, Deuschl G, Coelho M, Sampaio C, Abele M, Klockgether T, Schimke N, Eggert KM, Oertel W, Djaldetti R, Colosimo C, Meco G, Poewe W, Wenning GK. (2006)
Health-related quality of life in multiple system atrophy.
Mov Disord. 2006 Jun;21(6):809-15.
Seppi K, Schocke MF, Prennschuetz-Schuetzenau K, Mair KJ, Esterhammer R, Kremser C, Muigg A, Scherfler C, Jaschke W, Wenning GK, Poewe W. (2006)
Topography of putaminal degeneration in multiple system atrophy: A diffusion magnetic resonance study.
Mov Disord. 2006 Jun;21(6):847-52.
Seppi K, Schocke MF, Mair KJ, Esterhammer R, Weirich-Schwaiger H, Utermann B, Egger K, Brenneis C, Granata R, Boesch S, Poewe W, Wenning GK. (2006)
Diffusion-weighted imaging in Huntington's disease.
Mov Disord. 2006 Jul;21(7):1043-7.
Peralta C, Wolf E, Alber H, Seppi K, Müller S, Bösch S, Wenning GK, Pachinger O, Poewe W. (2006)
Valvular heart disease in Parkinson's disease vs. controls: An echocardiographic study.
Mov Disord. 2006 Aug;21(8):1109-13.
Seppi K, Högl B, Diem A, Peralta C, Wenning GK, Poewe W. (2006)
Levodopa-induced sleepiness in the Parkinson variant of multiple system atrophy.
Mov Disord. 2006 Aug;21(8):1281-3.
Geser F, Wenning GK. (2006)
The diagnosis of multiple system atrophy.
J Neurol. 2006 Aug;253 Suppl 3:iii2-iii15.
Seppi K, Scherfler C, Donnemiller E, Virgolini I, Schocke MF, Goebel G, Mair KJ, Boesch S, Brenneis C, Wenning GK, Poewe W. (2006)
Topography of dopamine transporter availability in progressive supranuclear palsy: a voxelwise [123I]beta-CIT SPECT analysis.
Arch Neurol. 2006 Aug;63(8):1154-60.
Boesch SM, Frauscher B, Brandauer E, Wenning GK, Poewe W, Hogl B. (2006)
Restless legs syndrome and motor activity during sleep in spinocerebellar ataxia type 6.
Sleep Med. 2006 Sep;7(6):529-32.
Metzger S, Bauer P, Tomiuk J, Laccone F, Didonato S, Gellera C, Mariotti C, Lange HW, Weirich-Schwaiger H, Wenning GK, Seppi K, Melegh B, Havasi V, Baliko L, Wieczorek S, Zaremba J, Hoffman-Zacharska D, Sulek A, Basak AN, Soydan E, Zidovska J, Kebrdlova V, Pandolfo M, Ribai P, Kadasi L, Kvasnicova M, Weber BH, Kreuz F, Dose M, Stuhrmann M, Riess O. (2006)
Genetic analysis of candidate genes modifying the age-at-onset in Huntington's disease.
Hum Genet. 2006 Sep;120(2):285-92.
Scherfler C, Boesch SM, Donnemiller E, Seppi K, Weirich-Schwaiger H, Goebel G, Virgolini I, Wenning GK, Poewe W. (2006)
Topography of cerebral monoamine transporter availability in families with SCA2 mutations: a voxel-wise [(123)I]beta-CIT SPECT analysis.
Eur J Nucl Med Mol Imaging. 2006 Sep;33(9):1084-90.
Boesch SM, Frauscher B, Brandauer E, Wenning GK, Hogl B, Poewe W. (2006)
Disturbance of rapid eye movement sleep in spinocerebellar ataxia type 2.
Mov Disord. 2006 Oct;21(10):1751-4.
Rinnerthaler M, Mueller J, Weichbold V, Wenning GK, Poewe W. (2006)
Social stigmatization in patients with cranial and cervical dystonia.
Mov Disord. 2006 Oct;21(10):1636-40.
Seppi K, Peralta C, Diem-Zangerl A, Puschban Z, Mueller J, Poewe W, Wenning GK. (2006)
Placebo-controlled trial of riluzole in multiple system atrophy.
Eur J Neurol. 2006 13:1146-8.
Hauser RA, Russ H, Haeger DA, Bruguiere-Fontenille M, Muller T, Wenning GK. (2006)
Patient Evaluation of a Home Diary to Assess Duration and Severity of Dyskinesia in Parkinson Disease.
Clin Neuropharmacol. 2006 November/December;29(6):322-30.
2005
Wenning GK, on behalf of the Working Group on Atypical Parkinsonism of the Austrian Parkinson’s Society. (2005)
Placebo-Controlled Trial of Amantadine in Multiple-System Atrophy.
Clin Neuropharmacol. 2005;28:225–7.
Stampfer-Kountchev, M.; Poewe, W.; Wenning, GK. (2005)
The postural tachycardia syndrome (POTS).
Aktuelle Neurologie. 2005;32(8):472-6.
Seppi K, Yekhlef F, Diem A, Luginger-Wolf E, Müller J, Tison F, Quinn NP, Poewe W, Wenning GK. (2005)
Progression of parkinsonism in multiple system atrophy.
J Neurol. 2005 Jan;252(1):91-6.
Scherfler C, Scholz SW, Donnemiller E, Decristoforo C, Oberladstätter M, Stefanova N, Diederen E, Virgolilni I, Poewe W, Wenning GK. (2005)
Evaluation of [123I]IBZM pinhole SPECT for the detection of striatal dopamine D2 receptor availability in rats.
Neuroimage. 2005 Feb;24(3):822-31.
Mantoan L, Stefanova N, Egger KE, Jellinger KA, Poewe W, Wenning GK. (2005)
Failure of caspase inhibition in the double-lesion rat model of striatonigral degeneration (multiple system atrophy).
Acta Neuropathol (Berl). 2005 Feb;109(2):191-7.
Stefanova N, Reindl M, Neumann M, Haass C, Poewe W, Kahle PJ, Wenning GK. (2005)
Oxidative stress in transgenic mice with oligodendroglial alpha-synuclein overexpression replicates the characteristic neuropathology of multiple system atrophy.
Am J Pathol. 2005 Mar;166(3):869-76.
Diguet E, Fernagut PO, Scherfler C, Wenning G, Tison F. (2005)
Effects of riluzole on combined MPTP + 3-nitropropionic acid-induced mild to moderate striatonigral degeneration in mice.
J Neural Transm. 2005 May;112(5):613-31.
Högl B, Kiechl S, Willeit J, Saletu M, Frauscher B, Seppi K, Müller J, Rungger G, Gasperi A, Wenning G, Poewe W. (2995)
Restless legs syndrome: a community-based study of prevalence, severity, and risk factors.
Neurology. 2005 Jun;64(11):1920-4.
Scherfler C, Seppi K, Donnemiller E, Goebel G, Brenneis C, Virgolini I, Wenning GK, Poewe W. (2005)
Voxel-wise analysis of [123I]beta-CIT SPECT differentiates the Parkinson variant of multiple system atrophy from idiopathic Parkinson's disease.
Brain. 2005 Jul;128(Pt 7):1605-12.
Jellinger KA, Seppi K, Wenning GK. (2005)
Grading of neuropathology in multiple system atrophy: proposal for a novel scale.
Mov Disord. 2005 Aug;20(Suppl 12):S29-36.
Stefanova N, Tison F, Reindl M, Poewe W, Wenning GK. (2005)
Animal models of multiple system atrophy.
Trends Neurosci. 2005 Sep;28(9):501-6.
Stefanova N, Reindl M, Poewe W, Wenning GK. (2005)
In vitro models of multiple system atrophy.
Mov Disord. 2005 Aug;20(Suppl 12):S53-6.
Wenning GK, Geser F, Poewe W. (2005)
Therapeutic strategies in multiple system atrophy.
Mov Disord. 2005 Aug;20(Suppl 12):S67-76.
Scherfler C, Sather T, Diguet E, Stefanova N, Puschban Z, Tison F, Poewe W, Wenning GK. (2005)
Riluzole improves motor deficits and attenuates loss of striatal neurons in a sequential double lesion rat model of striatonigral degeneration (parkinson variant of multiple system atrophy).
J Neural Transm. 2005 Aug;112(8):1025-33.
Kamm C, Healy DG, Quinn NP, Wullner U, Moller JC, Schols L, Geser F, Burk K, Borglum AD, Pellecchia MT, Tolosa E, del Sorbo F, Nilsson C, Bandmann O, Sharma M, Mayer P, Gasteiger M, Haworth A, Ozawa T, Lees AJ, Short J, Giunti P, Holinski-Feder E, Illig T, Wichmann HE, Wenning GK, Wood NW, Gasser T; European Multiple System Atrophy Study Group. (2005)
The fragile X tremor ataxia syndrome in the differential diagnosis of multiple system atrophy: data from the EMSA Study Group.
Brain. 2005 Aug;128(Pt 8):1855-60.
Berciano J, Wenning GK. (2005)
The Lewis family revisited: no evidence for autosomal dominant multiple system atrophy.
Park Relat Disord. 2005 Sep;11(6):363-5.
Wenning GK; Working (2005)
Group on Atypical Parkinsonism of the Austrian Parkinson’s Society. Placebo-controlled trial of amantadine in multiple-system atrophy.
Clin Neuropharmacol. 2005 Sep-Oct;28(5):225-7.
Schmidauer C, Sojer M, Seppi K, Stockner H, Högl B, Biedermann B, Brandauer E, Peralta CM, Wenning GK, Poewe W. (2005)
Transcranial ultrasound shows nigral hypoechogenicity in restless legs syndrome.
Ann Neurol. 2005 Oct;58(4):630-4.
Muller UJ, Frick B, Winkler C, Fuchs D, Wenning GK, Poewe W, Müller J. (2005)
Homocysteine and serum markers of immune activation in primary dystonia.
Mov Disord. 2005 Dec;20(12):1663-7.
Wenning GK, Kiechl S, Seppi K, Müller J, Högl B, Saletu M, Rungger G, Gasperi A, Willeit J, Poewe W. (2005)
Prevalence of movement disorders in men and women aged 50-89 years (Bruneck Study cohort): a population-based study.
Lancet Neurol. 2005 Dec;4(12):815-20.
Colosimo C, Gilman S, Quinn N, Wenning GK. (2005)
Preface - Special issue: Multiple system atrophy.
J Neural Transm. 2005 Dec;112(12):1601-3.
Puschban Z, Stefanova N, Petersen A, Winkler C, Brundin P, Poewe W, Wenning GK. (2005)
Evidence for dopaminergic re-innervation by embryonic allografts in an optimized rat model of the Parkinsonian variant of multiple system atrophy.
Brain Res Bull. 2005 Dec 15;68(1-2):54-8.
